By Jeremy Schwartz, CFA, Global Head of Research;Kara Marciscano, CFA, Associate, Research
If the 19th century was the century of chemistry and the 20th the century of physics, the 21st will be the century of biology. Jamie Metzl
Revolutionary advances across multiple fields including computer science, artificial intelligence, big data analytics, automation, chemistry, biology and engineering are creating previously unimaginable new opportunities to reengineer biological systems in ways that will revolutionize health care, agriculture, manufacturing, energy production, consumer services and data storage.
The revolution in our ability to read, understand, write and hack DNA, the genetic code of all life, will touch most aspects of how we live.
All organisms have their own genome, a complete set of DNA that contains instructions to develop and direct the activities of life.
Researchers can sequence DNA (determine the order and information carried in DNA) more rapidly and cost-effectively than ever before, which is driving transformations in health care and many other sectors of our global economy.
The development of Modernas COVID-19 vaccine is just one poignant exampleit took the company only two days to design the sequence for its mRNA vaccine!1
We believe the biology revolution is creating a historic investment opportunity equivalent to the industrial and internet revolutions, and theWisdomTree BioRevolution Fund (WDNA)may be uniquely positioned to capture the companies at the intersection of science, technology and engineering.
WDNA seeks to track the price and yield performance, before fees and expenses, of theWisdomTree BioRevolution Index (WTDNA), which provides targeted exposure to companies that we believe lead the transformations and advancements in genetics and biotechnology.
To construct the WisdomTree BioRevolution Index, we leverage data from leading technology futurist2Dr. Jamie Metzl as a third-party consultant. Recognized as a thought leader on the biology revolution, Dr. Metzl authored Hacking Darwin: Genetic Engineering and the Future of Humanity, and he serves as a member of the World Health Organizations expert committee on human genome editing.
Considering proprietary data from Dr. Metzl, WTDNA identifies the key sectors and industry verticals that are expected to be most significantly transformed by advances in biological science and technology, as well as the companies that WisdomTree believes are most representative of this wave of innovation.
The technologies underpinning the biology revolution are connected and reinforce advancements across interdisciplinary fields. We have identified four key BioRevolution sectors, each including multiple subsectors of impact.
Human Health The genetics and biotechnology revolutions are most often associated with health care because many of the most high-profile preliminary applications are health care related. The quantity and quality of these applications will increase significantly as our health care systems transition from generalized medicine based on population averages to personalized, or precision, health care based on each persons individual biology. When the amount of data collected on the human genome reaches critical mass, our system will transition to a predictive and preventive health care system that will help us live healthier and longer lives.
Although health care is the most mature market to date, we expect other sectors to catch up.
Agriculture & Food Technologies will supercharge the selective breeding process to accomplish in months or a few years what previously might have taken centuries or millennia. Pest resistance, yield and variety can be enhanced significantly for staple crops, which can also be engineered to significantly increase photosynthesis to slow climate change. Domesticated animals can be engineered to increase disease resistance, productivity and product quality through marker-assisted selective breeding targeting specific desired outcomes.
Materials Chemicals & Energy The sourcing of industrial inputs for manufacturing is another area ripe for transformation. As the human population grows toward an estimated 10 billion people by mid-century, current resource extraction models will not be sustainable. The tools of the genetics and biotechnology revolutions, however, are making it possible to create materials at scale by manipulating genetic code rather than extracting them from nature. Instead of making plastic from petroleum and fragrances from flowers, for example, we can produce both through the genetic engineering of yeast and other microbes.
Biological Machines & Interfaces Connection and communication between the biology of humans and computers, including the use of DNA for computing and storage, is increasing the potential to extract, store and process data from individuals.
WTDNA currently holds approximately 80% of its weight within the Human Health sector. Over time, we expect the maturation of Agriculture & Food as well as Materials, Chemicals & Energy to drive their increased representation in WTDNA.
Although the general direction and accelerating pace of this revolution are nearly certain, the time horizons for how each specific application will play out will vary. Our approach targets dynamic companies deploying revolutionary technologies both in and outside of health care, and it invests in a wide range of 115 companies across the BioRevolution impact spectrum to reduce single-stock concentration risk.
We believe the diverse portfolio of companies captured in WDNA is the best way for investors to gain exposure to the biology revolution that we expect to fundamentally transform our world and lives over the coming years.
Originally published by WisdomTree, 6/3/21
1As of 5/25/21, WTDNA held 0.6% of its weight in Moderna.2An individual who studies or predicts the future based on current trends in technology
Important Risks Related to this Article
There are risks associated with investing, including possible loss of principal. The Fund invests in BioRevolution companies, which are companies significantly transformed by advancements in genetics and biotechnology. BioRevolution companies face intense competition and potentially rapid product obsolescence. These companies may be adversely affected by the loss or impairment of intellectual property rights and other proprietary information or changes in government regulations or policies. Additionally, BioRevolution companies may be subject to risks associated with genetic analysis. The Fund invests in the securities included in, or representative of, its Index regardless of their investment merit, and the Fund does not attempt to outperform its Index or take defensive positions in declining markets. The composition of the Index is governed by an Index Committee, and the Index may not perform as intended. Please read the Funds prospectus for specific details regarding the Funds risk profile.
U.S. investors only: Clickhereto obtain a WisdomTree ETF prospectus which contains investment objectives, risks, charges, expenses, and other information; read and consider carefully before investing.
There are risks involved with investing, including possible loss of principal. Foreign investing involves currency, political and economic risk. Funds focusing on a single country, sector and/or funds that emphasize investments in smaller companies may experience greater price volatility. Investments in emerging markets, currency, fixed income and alternative investments include additional risks. Please see prospectus for discussion of risks.
Past performance is not indicative of future results. This material contains the opinions of the author, which are subject to change, and should not to be considered or interpreted as a recommendation to participate in any particular trading strategy, or deemed to be an offer or sale of any investment product and it should not be relied on as such. There is no guarantee that any strategies discussed will work under all market conditions. This material represents an assessment of the market environment at a specific time and is not intended to be a forecast of future events or a guarantee of future results. This material should not be relied upon as research or investment advice regarding any security in particular. The user of this information assumes the entire risk of any use made of the information provided herein. Neither WisdomTree nor its affiliates, nor Foreside Fund Services, LLC, or its affiliates provide tax or legal advice. Investors seeking tax or legal advice should consult their tax or legal advisor. Unless expressly stated otherwise the opinions, interpretations or findings expressed herein do not necessarily represent the views of WisdomTree or any of its affiliates.
The MSCI information may only be used for your internal use, may not be reproduced or re-disseminated in any form and may not be used as a basis for or component of any financial instruments or products or indexes. None of the MSCI information is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. Historical data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. The MSCI information is provided on an as is basis and the user of this information assumes the entire risk of any use made of this information. MSCI, each of its affiliates and each entity involved in compiling, computing or creating any MSCI information (collectively, the MSCI Parties) expressly disclaims all warranties. With respect to this information, in no event shall any MSCI Party have any liability for any direct, indirect, special, incidental, punitive, consequential (including loss profits) or any other damages (www.msci.com)
Jonathan Steinberg, Jeremy Schwartz, Rick Harper, Christopher Gannatti, Bradley Krom, Tripp Zimmerman, Michael Barrer, Anita Rausch, Kevin Flanagan, Brendan Loftus, Joseph Tenaglia, Jeff Weniger, Matt Wagner, Alejandro Saltiel, Ryan Krystopowicz, Kara Marciscano, Jianing Wu and Brian Manby are registered representatives of Foreside Fund Services, LLC.
WisdomTree Funds are distributed by Foreside Fund Services, LLC, in the U.S. only.
You cannot invest directly in an index.
See the rest here:
Gaining Exposure to the BioRevolution Megatrend - ETF Trends
- Genetic Engineering (excerpt) - Video [Last Updated On: January 9th, 2012] [Originally Added On: January 9th, 2012]
- Promising early results with therapeutic cancer vaccines [Last Updated On: February 16th, 2012] [Originally Added On: February 16th, 2012]
- Genetic Risk and Stressful Early Infancy Join to Increase Risk for Schizophrenia [Last Updated On: March 27th, 2012] [Originally Added On: March 27th, 2012]
- Innovative cell printing technologies hold promise for tissue engineering R&D [Last Updated On: March 28th, 2012] [Originally Added On: March 28th, 2012]
- SAGE® Labs Creates The First Tissue-Specific Gene Deletion In Rats [Last Updated On: April 21st, 2012] [Originally Added On: April 21st, 2012]
- Devangshu Datta: Towards an HIV cure [Last Updated On: May 5th, 2012] [Originally Added On: May 5th, 2012]
- Now *This* Is a Cell Phone: Using Radio Waves to Control Specific Genes in Mice | 80beats [Last Updated On: May 11th, 2012] [Originally Added On: May 11th, 2012]
- Genetic packing: Successful stem cell differentiation requires DNA compaction, study finds [Last Updated On: May 11th, 2012] [Originally Added On: May 11th, 2012]
- Premier issue of BioResearch Open Access launched by Mary Ann Liebert Inc. publishers [Last Updated On: May 17th, 2012] [Originally Added On: May 17th, 2012]
- GEN reports on growth of tissue engineering revenues [Last Updated On: July 11th, 2012] [Originally Added On: July 11th, 2012]
- New therapeutic target for prostate cancer identified [Last Updated On: July 18th, 2012] [Originally Added On: July 18th, 2012]
- Novel pig model may be useful for human cancer studies [Last Updated On: July 24th, 2012] [Originally Added On: July 24th, 2012]
- New gene therapy strategy boosts levels of deficient protein in Friedreich's ataxia [Last Updated On: July 25th, 2012] [Originally Added On: July 25th, 2012]
- Should high-dose interleukin-2 continue to be the treatment of choice for metastatic melanoma? [Last Updated On: July 26th, 2012] [Originally Added On: July 26th, 2012]
- New marker for identifying precursors to insulin-producing cells in pancreas [Last Updated On: August 22nd, 2012] [Originally Added On: August 22nd, 2012]
- 3D Biomatrix’s Perfecta3D® Hanging Drop Plates Featured in Prominent Life Science Journals [Last Updated On: October 1st, 2012] [Originally Added On: October 1st, 2012]
- Progress in Cell-SELEX compound screening technology reviewed in BioResearch Open Access [Last Updated On: October 18th, 2012] [Originally Added On: October 18th, 2012]
- Can the addition of radiolabeled treatments improve outcomes in advanced metastatic disease? [Last Updated On: November 14th, 2012] [Originally Added On: November 14th, 2012]
- Is the detection of early markers of Epstein Barr virus of diagnostic value? [Last Updated On: November 18th, 2012] [Originally Added On: November 18th, 2012]
- Genetic Engineering Of Mesenchymal Stem Cells - Video [Last Updated On: November 18th, 2012] [Originally Added On: November 18th, 2012]
- Ramble: Simelweis Taboo - Video [Last Updated On: December 12th, 2012] [Originally Added On: December 12th, 2012]
- The Super Protein That Can Cut DNA and Revolutionize Genetic Engineering [Last Updated On: March 22nd, 2013] [Originally Added On: March 22nd, 2013]
- Cellular Dynamics International Expands MyCell Products Line with Disease Models, Genetic Engineering Patents [Last Updated On: June 5th, 2013] [Originally Added On: June 5th, 2013]
- World Stem Cell Summit to be presented by Genetics Policy Institute, Mary Ann Liebert, Inc., and Genetic Engineering ... [Last Updated On: June 11th, 2013] [Originally Added On: June 11th, 2013]
- Genetic engineering - Wikipedia, the free encyclopedia [Last Updated On: November 1st, 2013] [Originally Added On: November 1st, 2013]
- Genetic Engineering: What is Genetic Engineering? [Last Updated On: November 1st, 2013] [Originally Added On: November 1st, 2013]
- Critical factor (BRG1) identified for maintaining stem cell pluripotency [Last Updated On: February 7th, 2014] [Originally Added On: February 7th, 2014]
- Genome Surgery [Last Updated On: February 11th, 2014] [Originally Added On: February 11th, 2014]
- Engineering The Human Genome One Letter At A Time [Last Updated On: February 11th, 2014] [Originally Added On: February 11th, 2014]
- CRISPR is the technology that could allow researchers to perform microsurgery on genes [Last Updated On: February 15th, 2014] [Originally Added On: February 15th, 2014]
- Joseph Glorioso, Ph.D., receives Pioneer Award [Last Updated On: February 19th, 2014] [Originally Added On: February 19th, 2014]
- Commentary: field of tissue engineering is progressing at remarkable pace [Last Updated On: March 5th, 2014] [Originally Added On: March 5th, 2014]
- Pioneer Award recipients Marina Cavazzana and Adrian Thrasher recognized for advancing gene therapy to the clinic for ... [Last Updated On: March 24th, 2014] [Originally Added On: March 24th, 2014]
- New method yields potent, renewable human stem cells with promising therapeutic properties [Last Updated On: March 25th, 2014] [Originally Added On: March 25th, 2014]
- First evidence that very small embryonic-like stem cells [Last Updated On: April 2nd, 2014] [Originally Added On: April 2nd, 2014]
- Scarless wound healing -- applying lessons learned from fetal stem cells [Last Updated On: April 11th, 2014] [Originally Added On: April 11th, 2014]
- Novel marker discovered for stem cells derived from human umbilical cord blood [Last Updated On: April 18th, 2014] [Originally Added On: April 18th, 2014]
- GENs Top 10 Session Picks for the 2014 BIO International Convention [Last Updated On: May 2nd, 2014] [Originally Added On: May 2nd, 2014]
- A Vaccine for Heart Disease Could Mean No Pills, Lettuce or a Gym [Last Updated On: June 14th, 2014] [Originally Added On: June 14th, 2014]
- Gene editing tool can write HIV out of the picture [Last Updated On: June 22nd, 2014] [Originally Added On: June 22nd, 2014]
- Inner ear stem cells hold promise for restoring hearing [Last Updated On: June 24th, 2014] [Originally Added On: June 24th, 2014]
- New method to grow zebrafish embryonic stem cells can regenerate whole fish [Last Updated On: June 30th, 2014] [Originally Added On: June 30th, 2014]
- Novel methods may help stem cells survive transplantation into damaged tissues [Last Updated On: July 22nd, 2014] [Originally Added On: July 22nd, 2014]
- New method for reducing tumorigenicity in induced pluripotent stem-cell based therapies [Last Updated On: July 24th, 2014] [Originally Added On: July 24th, 2014]
- Malcolm K. Brenner receives Pioneer Award for advances in gene-modified T cells targeting cancer [Last Updated On: July 26th, 2014] [Originally Added On: July 26th, 2014]
- Conclusive evidence on role of circulating mesenchymal stem cells in organ injury [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- New genomic editing methods produce better disease models from patient-derived iPSCs [Last Updated On: September 8th, 2014] [Originally Added On: September 8th, 2014]
- Tory Williams combats controversy surrounding stem cell therapy with new book [Last Updated On: September 11th, 2014] [Originally Added On: September 11th, 2014]
- NYIT Expert Predicts Growth in Demand for 3D Kidneys, Livers and Hearts [Last Updated On: December 9th, 2014] [Originally Added On: December 9th, 2014]
- The 'Berlin patient,' first and only person cured of HIV, speaks out [Last Updated On: January 6th, 2015] [Originally Added On: January 6th, 2015]
- Integrins are essential in stem cell binding to defective cartilage for joint regeneration [Last Updated On: January 27th, 2015] [Originally Added On: January 27th, 2015]
- Scientists urge caution in using new CRISPR technology to treat human genetic disease [Last Updated On: March 20th, 2015] [Originally Added On: March 20th, 2015]
- Scientists call for caution in using DNA-editing technology [Last Updated On: March 23rd, 2015] [Originally Added On: March 23rd, 2015]
- 'Ban DNA Editing Of Sperm And Eggs' [Last Updated On: March 23rd, 2015] [Originally Added On: March 23rd, 2015]
- Mount Sinai Researchers Discover Genetic Origins of Myelodysplastic Syndrome Using Stem Cells [Last Updated On: March 26th, 2015] [Originally Added On: March 26th, 2015]
- Researchers discover genetic origins of myelodysplastic syndrome using stem cells [Last Updated On: March 26th, 2015] [Originally Added On: March 26th, 2015]
- Pulling the strings of our genetic puppetmasters [Last Updated On: April 6th, 2015] [Originally Added On: April 6th, 2015]
- Going deep on life extension investments and human genetic engineering (Morning Read) [Last Updated On: April 6th, 2015] [Originally Added On: April 6th, 2015]
- Genetic engineering: a guide for kids by Tiki the Penguin [Last Updated On: July 8th, 2015] [Originally Added On: July 8th, 2015]
- genetic engineering | Britannica.com [Last Updated On: July 20th, 2015] [Originally Added On: July 20th, 2015]
- Interactives . DNA . Genetic Engineering [Last Updated On: August 3rd, 2015] [Originally Added On: August 3rd, 2015]
- Genetic engineering - Memory Alpha, the Star Trek Wiki [Last Updated On: September 10th, 2015] [Originally Added On: September 10th, 2015]
- Genetic Engineering Careers in India : How to become a ... [Last Updated On: September 10th, 2015] [Originally Added On: September 10th, 2015]
- Genetic Engineering (song) - Wikipedia, the free encyclopedia [Last Updated On: August 8th, 2016] [Originally Added On: August 8th, 2016]
- Genetic Engineering - BiologyMad [Last Updated On: September 28th, 2016] [Originally Added On: September 28th, 2016]
- UNL's AgBiosafety for Educators [Last Updated On: September 28th, 2016] [Originally Added On: September 28th, 2016]
- Recent Articles | Genetic Engineering | The Scientist ... [Last Updated On: October 20th, 2016] [Originally Added On: October 20th, 2016]
- Human Genetic Engineering - Popular Issues [Last Updated On: October 29th, 2016] [Originally Added On: October 29th, 2016]
- Explore More: Genetic Engineering - iptv.org [Last Updated On: October 29th, 2016] [Originally Added On: October 29th, 2016]
- Genetic Engineering and GM Crops - Pocket K | ISAAA.org [Last Updated On: November 10th, 2016] [Originally Added On: November 10th, 2016]
- Pros and Cons of Genetic Engineering | HRFnd [Last Updated On: November 10th, 2016] [Originally Added On: November 10th, 2016]
- Genetic Engineering - The New York Times [Last Updated On: November 10th, 2016] [Originally Added On: November 10th, 2016]
- Genetic Engineering | MSPCA-Angell [Last Updated On: November 10th, 2016] [Originally Added On: November 10th, 2016]
- What is genetic engineering? - Definition from WhatIs.com [Last Updated On: November 10th, 2016] [Originally Added On: November 10th, 2016]
- Genetic Engineering in Agriculture | Union of Concerned ... [Last Updated On: November 16th, 2016] [Originally Added On: November 16th, 2016]
- Free genetic engineering Essays and Papers - 123helpme [Last Updated On: November 20th, 2016] [Originally Added On: November 20th, 2016]
- Gene therapy - Wikipedia [Last Updated On: November 20th, 2016] [Originally Added On: November 20th, 2016]
- Writing the human genome - The Biological SCENE [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- America's First Free-Roaming Genetically Engineered Insects Are ... - Gizmodo [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- Stanford's Final Exams Pose Question About the Ethics of Genetic Engineering - Futurism [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]